1. Bailey TS, Alva S. Landscape of continuous glucose monitoring (CGM) and integrated CGM: accuracy considerations. Diabetes Technol Ther. 2021;23(S3):S5–11. https://doi.org/10.1089/dia.2021.0236.
2. U.S. Food & Drug Administration (FDA). Summary of safety and effectiveness data (SSED). https://www.accessdata.fda.gov/cdrh_docs/reviews/K193371.pdf. Accessed 5 Jul 2022.
3. U.S. Food & Drug Administration (FDA). Summary of safety and effectiveness data (SSED). https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160030B.pdf. Accessed 5 Jul 2022.
4. Abbott. Abbott receives CE mark for FreeStyle® Libre, a revolutionary glucose monitoring system for people with diabetes. 2014. https://abbott.mediaroom.com/2014-09-03-Abbott-Receives-CE-Mark-for-FreeStyle-Libre-a-Revolutionary-Glucose-Monitoring-System-for-People-with-Diabetes. Accessed 5 Jul 2022.
5. Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17(11):787–94.